Xin Long

Xin Long

Auto-generated profile, based on publicly available information

Xin Long

University of Texas Southwestern Medical Center 1 Division of Digestive and Liver Diseases, Department of Internal Medicine Dallas, TX

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
FLFurong Liu
Furong Liu
XLXin Long
Xin Long
BZBixiang Zhang
Bixiang Zhang
WZWanguang Zhang
Wanguang Zhang
XCXiaoping Chen
Xiaoping Chen
ZZZhan-Guo Zhang
Zhan-Guo Zhang

26 April 2012 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
LCLin Chen
Lin Chen
WZWei Zhang
Wei Zhang
QZQiao‐Dan Zhou
Qiao‐Dan Zhou
HYHong‐Qiang Yang
Hong‐Qiang Yang
HLHui‐Fang Liang
Hui‐Fang Liang
SHSen He
Sen He

14 June 2019 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
XCXiaoping Chen
Xiaoping Chen
XLXin Long
Xin Long
WJWen-Long Jia
Wen-Long Jia
HWHan-Jie Wu
Han-Jie Wu
JZJing Zhao
Jing Zhao
QCQian Chen
Qian Chen
Although the prognosis of patients with occult hepatitis B virus (HBV) infection (OBI) is usually benign, a small portion may undergo cirrhosis and subsequently hepatocellular carcinoma (HCC). We studied the mechanism of life-long Integration of virus DNA into OBI host’s genome, of which may induce hepatocyte transformation. We applied HBV capture sequencing on single cells from an OBI patient who, developed multiple HCC tumors and underwent liver resection in May 2013 at Tongji Hospital in China. Despite with the undetectable virus DNA in serum, we determined the pattern of viral integration in tumor cells and adjacent non-tumor cells and obtained the details of the viral arrangement in host genome, and furthermore the HBV integrated region in cancer genome. HBV captured sequencing of tissues and individual cells revealed that samples from multiple tumors shared two viral integration sites that could affect three host genes, including CSMD2 on chr1 and MED30/EXT1 on chr8. Whole genome sequencing further indicated one hybrid chromosome formed by HBV integrations between chr1 and chr8 that was shared by multiple tumors. Additional 50 poorly differentiated liver tumors and the paired adjacent non-tumors were evaluated and functional studies suggested up-regulated EXT1 expression promoted HCC growth. We further observed that the most somatic mutations within the tumor cell genome were common among the multiple tumors, suggesting that HBV associated, multifocal HCC is monoclonal in origin. Through analyzing the HBV integration sites in multifocal HCC, our data suggested that the tumor cells were monoclonal in origin and formed in the absence of active viral replication, whereas the affected host genes may subsequently contribute to carcinogenesis.

10 August 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XLXin Long
Xin Long
QCQian Chen
Qian Chen
JZJianping Zhao
Jianping Zhao
NRNicholas Rafaels
Nicholas Rafaels
PMPriyanka Mathias
Priyanka Mathias
SHSen He
Sen He
The aim of this study was to determine whether two polymorphisms in the gene encoding IL13 previously associated with Schistosoma hematobium (S. hematobium) and S. mansoni infection are associated with S. japonicum infection. Single nucleotide polymorphisms (SNPs) rs1800925 (IL13/-1112C>T) and rs20541 (IL13R130Q) were genotyped in 947 unrelated individuals (307 chronically infected, 339 late-stage with liver fibrosis, 301 uninfected controls) from a schistosomiasis-endemic area of Hubei province in China. Regression models were used to evaluate allelic and haplotypic associations with chronic and late-stage schistosomiasis adjusted for non-genetic covariates. Expression of IL-13 was measured in S. japonicun-infected liver fibrosis tissue and normal liver tissue from uninfected controls by immunohistochemistry (IHC). The role of rs1800925 in IL-13 transcription was further determined by Luciferase report assay using the recombinant PGL4.17-rs180092 plasmid. We found SNP rs1800925T was associated with late-stage schistosomiasis caused by S. japonicum but not chronic schistosomiasis (OR = 1.39, 95%CI = 1.02–1.91, p = 0.03) and uninfected controls (OR = 1.49, 95%CI = 1.03–2.13, p = 0.03). Moreover, the haplotype rs1800925T-rs20541C increased the risk of disease progression to late-stage schistosomiasis (OR = 1.46, p = 0.035), whereas haplotype rs1800925C-rs20541A showed a protective role against development of late-stage schistosomiasis (F = 0.188, OR = 0.61, p = 0.002). Furthermore, S. japonicum-induced fibrotic liver tissue had higher IL13 expression than normal liver tissue. Plasmid PGL4.17-rs1800925T showed a stronger relative luciferase activity than Plasmid PGL4.17-rs1800925C in 293FT, QSG-7701 and HL-7702 cell lines. In conclusion, the functional IL13 polymorphism, rs1800925T, previously associated with risk of schistosomiasis, also contributes to risk of late-stage schistosomiasis caused by S. japonicum.

1 February 2020 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
LZLei Zhang
Lei Zhang
ZZZhan-Guo Zhang
Zhan-Guo Zhang
XLXin Long
Xin Long
FLFei-Long Liu
Fei-Long Liu
WZWan-Guang Zhang
Wan-Guang Zhang
Background: Splenomegaly/hypersplenism is one of the most common complications of portal hypertension. Splenic artery embolization (SAE) has been increasingly used for treatment of splenomegaly/hypersplenism. However, few studies focused on the severe complications after embolization. In this paper, we reported 16 cases of severe complications after SAE for portal hypertension. Methods: From February 2011 to January 2019, 16 cirrhotic patients were diagnosed with severe complications after embolization. The clinical symptoms, therapies and prognosis were analyzed. Results: In these patients, the splenic embolization volume was between 50% and 70%. Among 16 cases, 7 patients were diagnosed with splenic abscess and/or left subphrenic abscess, suffered from the insistent fever, and eventually underwent the surgical therapy; 6 patients with left refractory pleural effusion, suffered from severe chest distress, and underwent repeated thoracocentesis or thoracic closed drainage; 3 patients with thrombosis in portal vein needed oral warfarin therapy. Conclusion: In cirrhotic patients, the severe complications after SAE are not uncommon after the procedure. It causes more suffering, prolonged hospital stay and more medical cost in these patients. It was debatable whether this technique was an appropriate technique for portal hypertension due to liver cirrhosis, patients contraindicated for the treatment should be carefully identified to avoid the complications.

18 October 2016 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
XLXin Long
Xin Long
JWJian Wang
Jian Wang
JZJian-Ping Zhao
Jian-Ping Zhao
HLHui-Fang Liang
Hui-Fang Liang
PZPeng Zhu
Peng Zhu
XCXiao-Ping Chen
Xiao-Ping Chen